Lishuang Lin
机构：Huashan Hospital
发表论文 10 篇 · 总被引 92 次 · h-index 3
代表论文
- ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc (2021 · Cancer Cell International · 被引 48)
- MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma (2024 · Biomarker Research · 被引 29)
- A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses (2023 · Journal of Translational Medicine · 被引 15)
- Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial (2026 · Figshare)
- Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial (2026 · Figshare)
- Additional file 1 of Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial (2026 · Figshare)